From Hurdles to Breakthroughs: Building and Validating a PSMA-positive Triple-Negative Breast Cancer Mouse Model for Preclinical Targeted Radionuclide TherapyBenjamin Chaussin(Inserm), E. Jouberton(Inserm)Research SquareNovember 11, 202510.21203/rs.3.rs-7904335/v1Cited by 0SaveCiteExport RISWatch citationsRelated PapersDevelopment and validation of a PSMA-positive triple-negative breast cancer mouse model for preclinical targeted radionuclide therapies|Scientific Reports|2026|0